NEW YORK (GenomeWeb News) – The biotechnology entrepreneur Alejandro Zaffaroni, who co-founded Affymetrix, has died at the age of 91, The New York Times has reported.

Originally from Uruguay, Zaffaroni helped to launch biotechnology and Silicon Valley companies beyond Affymetrix, including Alza, Syntex, Perlegen Sciences, Symyx Technologies, DNAX, and Maxygen. He also had a hand in bringing new technologies to market, including Affymetrix's biochips, as well as the birth control pill and the nicotine patch.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.